In our results it was possible to observe variations in plasma MBL levels in relation to polymorphic genotypes in patients with severe COVID-19 manifestations and patients with milder symptoms of the disease and showed that in both groups, polymorphic genotypes were associated with lower levels of MBL, but in the group of patients with severe COVID-19 this reduction was much more significant. Here, MBL2 is linked to COVID-19.